Shelby Geist, PA
Physician Assistant · Indianapolis, INNPI 1437826690
Payments from drug & device makers
Across 202 payments — averaging $19.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arcutis Biotherapeutics, Inc.$800
- AbbVie$626
- Sun Pharmaceutical Industries Inc.$458
- UCB, Inc.$333
- Johnson & Johnson$318
- Incyte Corporation$270
- plus $1K from 16 others
What the payments were for
- Consulting fees$72519%
- Food & beverage$3,05979%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 7 | $800 |
| AbbVie | 50 | $626 |
| Sun Pharmaceutical Industries Inc. | 26 | $458 |
| UCB, Inc. | 11 | $333 |
| Johnson & Johnson | 21 | $318 |
| Incyte Corporation | 19 | $270 |
| Novartis | 22 | $243 |
| Regeneron Healthcare Solutions, Inc. | 16 | $205 |
| Pfizer | 5 | $105 |
| Guard Medical Inc. | 1 | $100 |
| Lilly USA, LLC | 3 | $63 |
| Sanofi | 3 | $52 |
| Mayne Pharma Commercial LLC | 4 | $51 |
| Organon | 3 | $44 |
| Galderma Laboratories, L.p. | 2 | $42 |
| LEO Pharma Inc. | 2 | $34 |
| Journey Medical Corporation | 2 | $34 |
| E.r. Squibb & Sons, L.L.C. | 1 | $25 |
| Bristol Myers Squibb | 1 | $22 |
| Verrica Pharmaceuticals Inc. | 1 | $21 |
| Biofrontera Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Bimzelx$124
- Tremfya$118
- ZORYVE$113
- NPseal$100
- NPSEAL LARGE$100
- NPSEAL MEDIUM$100
How this compares
$3,884 in reported general payments places this provider in the 90th percentile of 1,955 physician assistant providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 17 | $62,112 |
| Fluorouracil | 20 | $1,849 |
| Clobetasol Propionate | 40 | $1,313 |
| Ketoconazole | 88 | $1,124 |
| Metronidazole | 16 | $1,033 |
| Triamcinolone Acetonide | 51 | $778 |
| Doxycycline Hyclate | 25 | $671 |
| Clindamycin Phosphate | 16 | $505 |
| Hydrocortisone | 64 | $377 |
| Mupirocin | 19 | $103 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Indianapolis
- Andrew NordIndianapolis$47K
- Qun Ming ZhangIndianapolis$28K
- Lindsay YoderIndianapolis$21K
- Mackenzie LawsonIndianapolis$15K
- Christina RaceIndianapolis$13K
- Zara BogenschutzIndianapolis$12K
- Ashley WorthingtonIndianapolis$11K
- Madison MaloofIndianapolis$10K
- Jason BrownIndianapolis$10K
- Michaela WehrIndianapolis$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.